SHH · 688331.SS
RemeGen Co. Ltd. Class A
CN¥93.23-CN¥0.39 (-0.42%)
RemeGen Co. Ltd. Class A’s quoted price sits in the lower half of its reported 52-week range, 40.92% below the high.
Loading market information…
SHH · 688837.SS · CNY
Stock price
Quote as of Oct 30, 2026, 05:58 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Evopoint Biosciences Co. Ltd.’s quoted price sits in the lower half of its reported 52-week range, 56.52% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Evopoint Biosciences Co., Ltd. operates as a biopharmaceutical company that offers therapies for patients with oncology and multidrug-resistant infections. The company's three core technology platforms are a Small Molecule Drug Discovery Platform, a Novel Antibody Discovery Platform, and a Targeted Protein Degradation Platform. Several of its pipeline products have advanced to Phase III clinical trials or the New Drug Application stage.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:13 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
CN¥93.23-CN¥0.39 (-0.42%)
RemeGen Co. Ltd. Class A’s quoted price sits in the lower half of its reported 52-week range, 40.92% below the high.
CN¥80.58-CN¥2.45 (-2.95%)
Shanghai Allist Pharmaceuticals Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 41.74% below the high.
CN¥40.63+CN¥0.59 (+1.47%)
Betta Pharmaceuticals Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 48.03% below the high.
CN¥17.09+CN¥0.11 (+0.65%)
Staidson (Beijing) BioPharmaceuticals Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 58.49% below the high.
CN¥20.19+CN¥0.04 (+0.2%)
Shenzhen Chipscreen Biosciences Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 44.64% below the high.
CN¥41.86+CN¥0.09 (+0.22%)
Chengdu Easton Biopharmaceuticals Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 47.99% below the high.
CN¥11.18+CN¥0.03 (+0.27%)
Jiangsu Yahong Meditech Co Ltd’s quoted price sits in the lower half of its reported 52-week range, 38.27% below the high.
CN¥16.30-CN¥2.72 (-14.3%)
Kexing Biopharm Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 60.72% below the high.
